V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240013751 | 240007408 | 1.78 | 75.4 | null | 2016-04-30 | 2016-06-08 | INTERLACE TRIAL | N | N | 240028802 | INTERLACE TRIAL |
| 240013752 | 240007409 | 1.63 | 67 | Palliative (P) | 2017-08-29 | 2017-08-30 | Azacitidine | 02 | N | 240028805 | AZACITIDINE |
| 240013753 | 240014142 | 1.54 | 69.5 | Disease modification (D) | 2013-10-10 | 2013-10-10 | Methotrexate intrathecal | N | N | 240028819 | METHOTREXATE INTRATHECAL |
| 240013754 | 240007414 | null | null | Palliative (P) | 2015-08-03 | 2015-08-13 | Azacitidine | null | N | 240028853 | AZACITIDINE |
| 240013755 | 240011987 | 1.71 | null | Curative (C) | 2017-12-20 | 2017-12-26 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240028857 | NOT MATCHED |
| 240013756 | 240007418 | 1.6 | 89.7 | Palliative (P) | 2015-06-15 | 2015-06-18 | Azacitidine | N | N | 240028879 | AZACITIDINE |
| 240013757 | 240016084 | 1.62 | 62 | Palliative (P) | null | 2017-01-12 | null | null | null | 240028929 | NOT MATCHED |
| 240013758 | 240007423 | 1.56 | null | null | null | 2018-08-23 | PACLITAXEL | Y | N | 240028962 | PACLITAXEL |
| 240013759 | 240007425 | null | 63 | Palliative (P) | null | 2014-07-25 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 240028963 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013760 | 240007427 | 1.63 | null | Palliative (P) | 2017-09-29 | 2017-09-30 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 240028977 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013761 | 240007432 | 1.52 | 62 | Palliative (P) | 2016-03-13 | 2016-04-03 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240029003 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013762 | 240015239 | 1.63 | 90.2 | Palliative (P) | 2015-02-09 | 2015-12-01 | INTERLACE TRIAL | N | Y | 240029011 | INTERLACE TRIAL |
| 240013763 | 240007434 | null | 92.5 | Palliative (P) | 2014-08-17 | 2014-08-29 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240029014 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013764 | 240007436 | 1.7 | 71 | Palliative (P) | null | 2018-01-27 | Bevacizumab | null | N | 240029023 | BEVACIZUMAB |
| 240013765 | 240007441 | 1.58 | 76 | Palliative (P) | 2016-09-20 | 2016-10-02 | INTERLACE TRIAL | N | N | 240029078 | INTERLACE TRIAL |
| 240013766 | 240014152 | 1.49 | null | Curative (C) | 2019-02-20 | 2019-03-12 | Paclitaxel 7 day | 2 | N | 240029078 | PACLITAXEL |
| 240013767 | 240016354 | 1.68 | 70.8 | Curative (C) | 2017-10-24 | 2017-11-06 | Trial Unspecified | N | N | 240029094 | TRIAL |
| 240013768 | 240007442 | 1.61 | 31.4 | Palliative (P) | 2016-08-04 | 2016-08-05 | Carboplatin AUC 2 - 5 | 2 | N | 240029094 | CARBOPLATIN |
| 240013769 | 240012004 | null | 87.1 | Curative (C) | 2014-03-29 | 2014-04-20 | Methotrexate intrathecal | N | N | 240029101 | METHOTREXATE INTRATHECAL |
| 240013770 | 240007445 | 1.55 | 73.4 | Disease modification (D) | null | 2015-05-25 | Trial Unspecified | 2 | N | 240029105 | TRIAL |
| 240013771 | 240012006 | null | 34.7 | Curative (C) | 2016-07-07 | 2016-07-07 | CHOP - 21 days | 02 | null | 240029124 | CHOP |
| 240013772 | 240007446 | null | null | Palliative (P) | 2015-05-23 | 2015-05-23 | Trial Unspecified | 02 | null | 240029160 | TRIAL |
| 240013773 | 240007449 | 1.68 | null | Palliative (P) | 2014-12-05 | 2014-12-12 | Methotrexate intrathecal | N | N | 240029169 | METHOTREXATE INTRATHECAL |
| 240013774 | 240015244 | null | 36.8 | null | 2017-01-03 | 2017-01-31 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 240029175 | NOT MATCHED |
| 240013775 | 240007452 | 1.65 | 65.9 | Adjuvant (A) | null | 2016-09-04 | Trial Unspecified | N | N | 240029181 | TRIAL |
| 240013776 | 240014158 | null | null | Palliative (P) | null | 2015-11-18 | Azacitidine | 02 | N | 240029191 | AZACITIDINE |
| 240013777 | 240007458 | 1.84 | 83.9 | Palliative (P) | 2014-06-23 | 2014-06-23 | PACLITAXEL | Y | null | 240029196 | PACLITAXEL |
| 240013778 | 240007461 | 1.61 | null | Palliative (P) | 2013-03-07 | 2013-03-28 | Bevacizumab 15mg/kg | n | N | 240029208 | BEVACIZUMAB |
| 240013779 | 240007464 | 1.66 | 84.6 | Palliative (P) | 2016-10-26 | 2016-11-09 | Bevacizumab+Carbo+Pacliaxel | 1 | N | 240029219 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240013780 | 240014160 | 1.73 | 77.2 | null | null | 2017-10-18 | Bevacizumab | N | N | 240029244 | BEVACIZUMAB |
| 240013781 | 240016086 | null | 36.8 | Curative (C) | 2016-04-04 | 2016-04-05 | INTERLACE TRIAL | 2 | N | 240029268 | INTERLACE TRIAL |
| 240013782 | 240007471 | 1.66 | 80 | Curative (C) | 2016-11-03 | 2016-11-16 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 240029276 | NOT MATCHED |
| 240013783 | 240007474 | 1.6 | 51.2 | null | 2018-06-05 | 2018-06-05 | Bevacizumab 15mg/kg | 02 | N | 240029284 | BEVACIZUMAB |
| 240013784 | 240007476 | 1.64 | 94.6 | Curative (C) | 2015-04-17 | 2015-08-01 | INTERLACE TRIAL | N | N | 240029309 | INTERLACE TRIAL |
| 240013785 | 240014162 | 1.55 | 65 | Palliative (P) | 2015-09-06 | 2015-09-15 | Azacitidine | 1 | N | 240029310 | AZACITIDINE |
| 240013786 | 240007478 | 1.57 | null | Palliative (P) | null | 2014-03-27 | CARBOPLATIN | N | N | 240029322 | CARBOPLATIN |
| 240013787 | 240007481 | 1.67 | 81 | Palliative (P) | 2018-05-16 | 2018-05-23 | Paclitaxel 7 day | N | N | 240029327 | PACLITAXEL |
| 240013788 | 240007486 | 1.46 | 86.7 | Neo-adjuvant (N) | null | 2017-08-12 | Trial Unspecified | 02 | N | 240029338 | TRIAL |
| 240013789 | 240007488 | 1.64 | 62.5 | null | 2016-01-24 | 2016-01-25 | Trial Unspecified | 01 | N | 240029351 | TRIAL |
| 240013790 | 240014165 | 1.64 | 86.5 | Disease modification (D) | 2014-07-10 | 2014-07-14 | Methotrexate intrathecal | 2 | N | 240029356 | METHOTREXATE INTRATHECAL |
| 240013791 | 240007491 | 1.8 | 68.4 | Palliative (P) | 2017-01-18 | 2017-02-09 | Bevacizumab | N | N | 240029376 | BEVACIZUMAB |
| 240013792 | 240015250 | 0 | 74.7 | Palliative (P) | 2014-02-10 | 2014-03-11 | Carboplatin AUC 2 - 5 | null | null | 240029415 | CARBOPLATIN |
| 240013793 | 240012030 | 1.68 | 44.8 | Not known (9) | null | 2015-10-01 | Bevacizumab 15mg/kg | N | N | 240029427 | BEVACIZUMAB |
| 240013795 | 240007506 | 1.64 | 21.6 | Curative (C) | 2015-12-07 | 2016-02-19 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 1 | Y | 240029468 | NOT MATCHED |
| 240013796 | 240007509 | null | null | Palliative (P) | 2016-01-12 | 2016-01-12 | Azacitidine | N | N | 240029482 | AZACITIDINE |
| 240013797 | 240007516 | 1.68 | 50.8 | Palliative (P) | 2017-10-09 | 2017-10-14 | PACLITAXEL | N | N | 240029542 | PACLITAXEL |
| 240013798 | 240007517 | 1.63 | 63.4 | null | 2017-12-29 | 2018-01-08 | Carboplatin AUC 2 - 5 | N | N | 240029547 | CARBOPLATIN |
| 240013799 | 240007518 | 1.67 | 98 | Palliative (P) | 2014-12-01 | 2014-12-02 | Methotrexate intrathecal | 2 | N | 240029551 | METHOTREXATE INTRATHECAL |
| 240013800 | 240007518 | null | 71 | Palliative (P) | 2015-04-19 | 2015-04-20 | Trial Unspecified | N | N | 240029551 | TRIAL |
| 240013801 | 240012041 | 1.74 | 21.5 | Neo-adjuvant (N) | 2013-10-24 | 2014-01-11 | Trial Unspecified | N | N | 240029565 | TRIAL |